• Company
• Livtencity's introduction raises expectations in the field
• by Hwang, Byung-woo Sep 10, 2024 05:47am

• Company
• Eliquis generics to enter and reshape DOAC mkt in SEP
• by Moon, Sung-ho Sep 10, 2024 05:47am

• Company
• Hugel hosts Train-The-Trainer seminar for global medical aes
• by Kwon Sung-Yong Sep 9, 2024 09:45am

• Company
• 'Vabysmo' likely to receive approval for third indication
• by Eo, Yun-Ho Sep 9, 2024 05:49am

• Policy
• MFDS announces EUA application of new COVID-19 vaccine
• by Lee, Hye-Kyung Sep 9, 2024 05:49am

• Company
• Jassen’s Balversa can be prescribed in general hospitals
• by Eo, Yun-Ho Sep 9, 2024 05:49am

• Company
• Vonjo receives orphan drug designation in Korea
• by Eo, Yun-Ho Sep 6, 2024 05:48am

• InterView
• "New targeted therapies for bile duct cancer are in need"
• by Son, Hyung-Min Sep 6, 2024 05:48am

• Company
• SGLI2i and dulaglutide similar in reducing dementia risk
• by Hwang, Byung-woo Sep 6, 2024 05:48am

• Policy
• COVID-19 drug Paxlovid’s price likely to be based on Japan
• by Lee, Tak-Sun Sep 6, 2024 05:48am